"Moment of Zen"  cover image

Trump, AI, and US-China Relations with Samuel Hammond and Nathan Labenz

"Moment of Zen"

00:00

Reimagining FDA Processes in the Age of AI

This chapter delves into Balaji Shunovasan's potential role as FDA commissioner and his innovative approach to drug approval processes. It emphasizes the shift towards a post-market surveillance model using AI and real-time data, while also addressing the political challenges involved.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app